Roman Trawicki - Mar 16, 2022 Form 4 Insider Report for Zoetis Inc. (ZTS)

Role: Executive Vice President
Signature: /s/ Brenda Santuccio, as Attorney-in-Fact
Stock symbol: ZTS
Transactions as of: Mar 16, 2022
Transactions value $: -$603,840
Form type: 4
Date filed: 3/18/2022, 04:38 PM
Previous filing: Feb 15, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZTS	Common Stock	Options Exercise	$525K	+6K	+73.01%	$87.51	14.2K	Mar 16, 2022	Direct
transaction	ZTS	Common Stock	Sale	-$1.13M	-6K	-42.2%	$188.15	8.22K	Mar 16, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZTS	Stock Option	Options Exercise	$0	-6K	-15.02%	$0.00	33.9K	Mar 16, 2022	Common Stock	6K		Direct	F2, F3, F4, F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.10 to $188.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
F3	6,000 options granted February 12, 2019 at an exercise price of $87.51 per option.
F4	Each option vests on the third anniversary of the date of grant.
F5	Each option expires on the tenth anniversary of the date of grant.
F6	7,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option; and 7,332 options granted February 8, 2022 at an exercise price of $201.30 per option.